Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATTENTION IV: Endovascular Thrombectomy Alone vs IV Thrombolysis + Thrombectomy in Acute Basilar Artery Occlusion
NCT05827042Phase 3Completed
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- May 2023
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
A Phase 3 trial of tissue-plasminogen activator, tenecteplase in basilar artery occlusion (BAO), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Started May 2023; status: completed.
02
Drugs
tissue-plasminogen activatortenecteplase
03
Conditions
basilar artery occlusion (BAO)
Beyond the preview
Go deeper on NCT05827042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05827042.